Attached files
| file | filename |
|---|---|
| EX-21 - EX-21 - Flexion Therapeutics Inc | d134391dex21.htm |
| EX-31.2 - EX-31.2 - Flexion Therapeutics Inc | d134391dex312.htm |
| EX-10.6 - EX-10.6 - Flexion Therapeutics Inc | d134391dex106.htm |
| EX-32.2 - EX-32.2 - Flexion Therapeutics Inc | d134391dex322.htm |
| EX-32.1 - EX-32.1 - Flexion Therapeutics Inc | d134391dex321.htm |
| EX-31.1 - EX-31.1 - Flexion Therapeutics Inc | d134391dex311.htm |
| EX-10.21 - EX-10.21 - Flexion Therapeutics Inc | d134391dex1021.htm |
| 10-K - FORM 10-K - Flexion Therapeutics Inc | d134391d10k.htm |
| EX-10.20 - EX-10.20 - Flexion Therapeutics Inc | d134391dex1020.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (Nos. 333-193907 and 333-202957) and Registration Statement on Form S-3 (No. 333-203706) of Flexion Therapeutics, Inc. of our report dated March 11, 2016 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 11, 2016